Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.

Samsung Biologics Co.,Ltd.

207940

Hisse Senetlerindeki Sıralama #496
Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon,... Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon, South Korea, provides contract services for biopharmaceutical products. The company's operations are divided into two main segments: Contract Manufacturing Organization (CMO) and Contract Development Organization (CDO). Its CDO services cover areas such as cell line development, optimization of upstream and downstream processes, and the formulation of analytical methods and final products. For CMO, the company offers aseptic filling, lyophilization, finishing, storage, shipping, and various associated support services. Additionally, it delivers comprehensive quality assurance, quality control, biosafety, and analytical testing. Samsung Biologics is also involved in creating and launching biosimilar drugs, alongside manufacturing mammalian cell-based antibody medications.
Hisse Fiyatı
$1,028.49
Piyasa Değeri
$47.88B
Değişim (1 gün)
-3.67%
Değişim (1 yıl)
-18.37%
Ülke
KR
Ticaret Samsung Biologics Co.,Ltd. (207940)

Kategori

Healthcare
Samsung Biologics Co.,Ltd. (207940) için P/B oranı
October 2026 itibarıyla P/B oranı TTM: 7.59
Samsung Biologics Co.,Ltd. şirketinin en son mali raporları ve hisse fiyatına göre, mevcut P/B oranı (TTM) 7.59'dir. 2024 yılının sonunda şirketin P/B oranı 6.19 idi.
Samsung Biologics Co.,Ltd. için P/B oranı geçmişi 2014 - 2026 arası
Her yılın sonunda P/B oranı
Yıl P/B Oranı Değiştir
2026 (TTM) 7.59 -27.89%
2025 10.52 69.82%
2024 6.19 8.43%
2023 5.71 -11.02%
2022 6.42 -46.93%
2021 12.10 0.73%
2020 12.01 80.63%
2019 6.65 10.48%
2018 6.02 -8.12%
2017 6.55 197.83%
2016 2.20 -43.49%
2015 3.89 -78.44%
2014 18.05 0.00%
Benzer şirketler veya rakipler için P/B oranı
Şirket P/B Oranı P/B Oranı Farkı Ülke
6.6964 -11.72%
US
13.6307 79.69%
US
4.4521 -41.31%
AU
4.2241 -44.31%
BE
6.3632 -16.11%
NL